Who profits from improved patient adherence?

Aside from patients who get better health outcomes because of better adherence, who profits (either from increased revenues or lower expenses) from improved patient adherence? On the revenue side are the pharmaceuticals. The simplest and most straight-forward answer is that pharmaceuticals would profit the most. After all, more adherence means more product usage, which means … Continue reading

What can make health insurers back down from a fight?

Blue Cross and Blue Shield of North Carolina has just launched a major multimedia campaign in an attempt to improve its image. In its website, BCBS portrays goats and asks us to choose a scape goat for rising healthcare costs: The attempt by BCBS of North Carolina to shore up its reputation comes at an interesting … Continue reading